Life as a public company continues to grow in complexity and challenges. It is essential to retain counsel with the securities experience and industry knowledge to guide you quickly and efficiently through everything from capital-raising transactions and sensitive disclosure issues, to Securities and Exchange Commission compliance and reporting, and corporate governance and stockholder interactions.
Mintz Levin represents issuers, underwriters, and investors in the full range of sophisticated securities transactions, from private placements and venture capital investments to initial and follow-on public offerings of equity, debt, and other securities, including registered direct offerings, PIPEs and confidentially marketed public offerings, and reverse mergers and other “alternative” means of accessing capital. We draw from extensive transactional experience and deep industry knowledge when representing you in your financing transactions and interactions with the Securities and Exchange Commission. We also represent buyers and sellers of businesses in merger and acquisition transactions in which securities are used as transaction consideration.
We represent our public company clients with respect to ongoing Securities and Exchange Commission compliance obligations, including periodic reporting, stockholder interactions, equity compensation matters, officer and director reporting requirements, and managing disclosure considerations. We also counsel companies and their boards of directors and board committees on the corporate governance obligations and requirements of the Dodd-Frank Act, Sarbanes-Oxley, and state corporate law. We approach sensitive disclosure issues with a comprehensive understanding of the industries in which you operate and the issues that are most important to you and your stockholders.
Quick Facts
- Recognized industry knowledge in life sciences, biotechnology, and energy and clean technology
- Completed more than 65 public offerings since 2010, with an aggregate deal value of over $3.7 billion
- Counsel to the world’s leading investment banks and many industry-focused niche and specialty firms
- Specialize in IPO work for companies developing ground-breaking technologies:
- First biotech: Biogen
- First demand response: EnerNOC
- First NYSE-listed SPAC: Navios Maritime
- Access to firm’s Securities Litigation attorneys
Areas of Focus
- Board and committee advice
- Counsel concerning the requirements and restrictions imposed on boards and board committees by securities laws
- Capital-raising transactions
- IPOs, underwritten follow-ons and registered directs, PIPEs, confidentially marketed public offerings, SPACs, and equity and debt offerings, including Rule 144A convertible notes
- Corporate governance strategies
- Sarbanes-Oxley and Dodd-Frank compliance and related governance issues
- Executive and equity compensation planning and implementation
- Structuring and implementing employee benefit plans and equity compensation packages under SEC’s “short-swing profit” reporting and liability rules, Section 13 and Section 16 reporting, and 10b5-1 plans
- SEC and stock exchange reporting
- Periodic and current reports, disclosure controls and procedures, and stock exchange listing standards
- Securities education and training
- Ensuring clients stay current with regulations and best practices
- Shareholder communications and reporting
- Assisting with the annual meeting process, Regulation FD compliance, and institutional shareholder issues
- Mergers and acquisitions involving public company securities
- Deal structuring, SEC disclosure and filings, corporate takeover defenses, and strategy
- Policies and procedures
- Implementing codes of conduct, insider trading policies and programs, and other means of managing life as a public company